Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.
- Status
- RECRUITING
- Phase
- N/A
HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)
- Status
- RECRUITING
- Phase
- PHASE3
AI-Based Multimodal Integration for Tumor Microenvironment Analysis and Response Prediction in HCC Treated With TACE Plus Immunotherapy and Targeted Therapy (CHANCE2601)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
YMN-A02 for Advanced Primary Hepatocellular Carcinoma.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase Ia/Ib Study of FXB0871 Monotherapy in Locally Advanced/Metastatic Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Outcomes After Liver and Biliary Resection at a High-Volume Center
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Sequential FOLFOX-HAIC-TACE Plus Sintilimab-Bevacizumab Neoadjuvant Therapy Versus Direct Resection in Resectable High-Risk Recurrence Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors
- Status
- RECRUITING
- Phase
- N/A
MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide
- Status
- RECRUITING
- Phase
- N/A
Adjuvant TACE in HCC With High-risk Recurrence Factors
- Status
- RECRUITING
- Phase
- PHASE3
Utility of MicroRNAs for Diagnosing Hepatocellular Carcinoma in Hepatitis C Patients
- Status
- COMPLETED
- Phase
- N/A
Phase II Trial of Immunonutrition in Hepatectomy
- Status
- RECRUITING
- Phase
- NA
Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer
- Status
- COMPLETED
- Phase
- N/A
MR 7700 Multinuclear Application Clinical Study
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1